Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,098,041 | 4,791,676 | 4,547,530 | 4,036,868 | 2,756,056 |
| Receivables | 1,056,177 | 938,019 | 865,080 | 863,281 | 770,776 |
| Inventories | 732,603 | 681,590 | 608,227 | 531,687 | 502,867 |
| TOTAL | $7,215,805 | $6,601,280 | $6,233,589 | $5,664,477 | $4,310,221 |
| Non-Current Assets | |||||
| PPE Net | 1,643,286 | 1,640,918 | 1,641,678 | 1,628,114 | 1,615,792 |
| Intangibles | 60,956 | 61,681 | 62,704 | 63,581 | 64,890 |
| Other Non-Current Assets | 255,568 | 249,740 | 250,602 | 276,414 | 307,491 |
| TOTAL | $1,959,810 | $1,952,339 | $1,954,984 | $1,968,109 | $1,988,173 |
| Total Assets | $9,175,615 | $8,553,619 | $8,188,573 | $7,632,586 | $6,298,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 470,299 | 423,546 | 479,035 | 383,676 | 360,783 |
| Accrued Expenses | 1,264,264 | 1,079,283 | 1,109,120 | 1,001,661 | 908,882 |
| Other current liabilities | 95,460 | 108,435 | 121,059 | 142,841 | 108,992 |
| TOTAL | $2,119,187 | $1,811,510 | $1,828,830 | $2,368,425 | $2,209,837 |
| Non-Current Liabilities | |||||
| Long Term Debt | 882,163 | 962,515 | 961,913 | 139,571 | 146,091 |
| Other Non-Current Liabilities | 942,879 | 963,286 | 983,427 | 948,198 | 127,898 |
| TOTAL | $1,882,430 | $1,981,667 | $1,998,549 | $1,134,835 | $318,082 |
| Total Liabilities | $4,001,617 | $3,793,177 | $3,827,379 | $3,503,260 | $2,527,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,702 | 111,174 | 110,943 | 110,658 | 110,029 |
| Common Shares | 147 | 144 | 144 | 144 | 143 |
| Retained earnings | -7,855,539 | -8,092,546 | -8,319,903 | -8,386,405 | -8,511,246 |
| Other shareholders' equity | -25,370 | -53,486 | -78,187 | -101,253 | -113,702 |
| TOTAL | $5,173,998 | $4,760,442 | $4,361,194 | $4,129,326 | $3,770,475 |
| Total Liabilities And Equity | $9,175,615 | $8,553,619 | $8,188,573 | $7,632,586 | $6,298,394 |